Which patients are you most likely to use cenobamate adjunctively in super-refractory status epilepticus?

This is a good question and the recent study from Campos-Fernandez et al., 42956387 tried to answer this question, though this is a small cohort with patients on a number of ASMs (IQR 4-5) already, so this needs to be kept in mind if one is considering cenobamate in SRSE.

In the hospital, we typicall...